Esta tradução está a ser preparada. Entretanto, mostramos temporariamente a versão original em inglês.
Negócios · 17/07/19981 min de leitura
Oral Dosage Form New Animal Drugs; Bacitracin Methylene Disalicylate Soluble
Tradução automática local · Idioma original da fonte
Resumo
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Alpharma Inc. The supplemental NADA provides for using soluble bacitracin methylene disalicylate (BMD) powder to make a medicated drinking water for growing quail for prevention of ulcerative enteritis.
Idioma original da fonte: Federal Register — Food and Drug AdministrationAbrir o comunicado original →